FPF
DFTX

First Pacific Financial’s Definium Therapeutics DFTX Stock Holding History

First Pacific Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-102
Closed -$662 – 548
2025
Q2 		$662 Buy
+102
New +$671 ﹤0.01% 465

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

First Pacific Financial's DFTX Position: Q3 2025 in Review

First Pacific Financial sold out of Definium Therapeutics (DFTX) in Q3 2025, closing a stake of 102 shares — an estimated $662 sold.

First Pacific Financial first reported a position in DFTX in Q2 2025 and held it in 1 quarter. The position peaked at $662 in Q2 2025. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • First Pacific Financial reported no remaining Definium Therapeutics position as of Q3 2025 after selling out during the quarter.
  • First Pacific Financial sold 102 Definium Therapeutics shares in Q3 2025, an estimated $662.
  • First Pacific Financial first reported a position in Definium Therapeutics in Q2 2025 and held it in 1 quarter.
  • First Pacific Financial's Definium Therapeutics position peaked at $662 in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on First Pacific Financial's 13F filing for Q3 2025, filed 21 Oct 2025.